Drug
Omadacycline
Omadacycline: highest development phase Phase 3, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Omadacycline NCT06162286 | Phase 3 | Community-acquired Bacterial Pneumonia |
Latest
No recent events.
Follow Omadacycline on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.